Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin

Background For patients with liver metastases from gastric cancer (LMGC), combination chemotherapy with fluoropyrimidines and platinum agents has been recognized as standard treatment. However, the prognosis of hepatic progression after first-line treatment failure remains poor. When hepatic progres...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta radiologica (1987) 2016-07, Vol.57 (7), p.781-788
Hauptverfasser:	Seki, Hiroshi, Ohi, Hiroyuki, Ozaki, Toshirou, Yabusaki, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Catheters, Indwelling Chemotherapy Cisplatin - administration & dosage Disease Progression Drug Combinations Epirubicin - administration & dosage Failure Female Fluorouracil - administration & dosage Hepatic Artery Humans Infusion Infusions, Intra-Arterial Liver Liver Neoplasms - drug therapy Liver Neoplasms - secondary Male Medical services Middle Aged Mitomycin - administration & dosage Oxonic Acid - administration & dosage Patients Progressions Stomach Neoplasms - pathology Survival Rate Tegafur - administration & dosage Tomography, X-Ray Computed Treatment Failure Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!